Anti-Aging Supplements: What the Research Actually Shows
Explore the clinic directoryIn this article
- How Aging Works (The Short Version)
- Which longevity supplements are supported by human trials?
- NAD+ Precursors: NMN and NR
- Resveratrol
- Coenzyme Q10 (CoQ10)
- Collagen Peptides
- Is oral collagen bioavailable? The evidence and the skeptics' case
- Spermidine
- Fisetin
- Rapamycin (Off-Label)
- Metformin (Off-Label)
- How to Evaluate Anti-Aging Supplement Claims
- Practical Takeaways
- Where clinic-based longevity treatments fit
- When to See a Doctor
- Frequently asked questions
- The Bottom Line
- Sources
Oral collagen is partly bioavailable: digestion breaks hydrolyzed collagen into amino acids and small peptides such as prolyl-hydroxyproline (Pro-Hyp), which researchers have measured in human blood after a dose, and a 2019 meta-analysis of 11 randomized controlled trials linked collagen peptides to better skin hydration, elasticity and wrinkle appearance. The skeptics' limits are real: most collagen trials are small, short and manufacturer funded, and across all longevity supplements only a few, such as CoQ10 in the Q-SYMBIO heart failure trial, have solid human outcome data.
What this article covers
- Oral collagen peptides reach the bloodstream partly as small hydroxyproline-containing peptides such as Pro-Hyp, according to Iwai and colleagues (2005), not as intact collagen.
- A 2019 meta-analysis of 11 randomized controlled trials found oral collagen improved skin hydration, elasticity and wrinkle appearance, but the trials are mostly small, short and industry funded.
- CoQ10 has the strongest outcome trial among anti-aging supplements: in Q-SYMBIO (Mortensen and colleagues, 2014), 300 mg daily for two years reduced major adverse cardiovascular events in 420 people with heart failure.
- The NAD+ precursors NMN and NR raise blood NAD+ in human trials (Martens, 2018; Liao, 2022), but no trial shows they extend lifespan or healthspan in people.
- Rapamycin and metformin are prescription drugs used off label for longevity, and the TAME trial of metformin in older adults without diabetes has not yet reported results.
- Exercise, sleep, a nutrient-dense diet and social connection have more consistent evidence for healthy aging than any pill reviewed here.
The anti-aging supplement market is projected to reach over $90 billion by 2030. Walk into any health food store or scroll through social media, and you will find dozens of pills, powders, and protocols promising to turn back biological aging. Some of these products are backed by real science. Others are mostly marketing dressed up in lab coats.
Each compound below is judged on the same terms: what the peer-reviewed human research actually supports, where the gaps remain, and which claims outrun the data. The list covers NAD+ precursors (NMN and NR), resveratrol, coenzyme Q10, collagen peptides, spermidine, fisetin, and two prescription drugs used off label for longevity, rapamycin and metformin.
How Aging Works (The Short Version)
Before evaluating specific supplements, it helps to understand the basic biology they are targeting. Researchers have identified several “hallmarks of aging,” including mitochondrial dysfunction, cellular senescence (zombie cells that accumulate over time), genomic instability, loss of proteostasis (the cell’s ability to maintain properly folded proteins), and chronic low-grade inflammation sometimes called “inflammaging” [1].
Anti-aging supplements aim to intervene in one or more of these pathways. The quality of evidence ranges from strong animal data with limited human trials to well-designed randomized controlled trials in humans.
Which longevity supplements are supported by human trials?
Only a handful of longevity supplements have randomized controlled trials in people, and almost none of those trials measure lifespan. Most human studies track a biomarker, such as blood NAD+, or a tissue outcome, such as skin elasticity. The strongest clinical outcome trial in this group belongs to CoQ10, and it was run in people with heart failure, not in healthy adults.
The table summarizes the strongest human evidence cited in each section below. A trial that raises a biomarker is useful, but it does not show that a supplement slows aging.
| Compound | Strongest human evidence cited here | What the human data shows | Evidence level |
|---|---|---|---|
| CoQ10 (ubiquinone) | Q-SYMBIO randomized trial, 420 heart failure patients, 300 mg daily for two years (Mortensen, 2014) | Fewer major adverse cardiovascular events in heart failure | Good for heart failure; moderate for general aging |
| Collagen peptides (hydrolyzed collagen) | 2019 meta-analysis of 11 randomized controlled trials | Better skin hydration, elasticity and wrinkle appearance; some joint pain benefit | Good for skin and joints; not a systemic anti-aging effect |
| Nicotinamide riboside (NR) | 2018 trial in middle-aged and older adults, 1,000 mg daily (Martens, 2018) | Well tolerated and raised blood NAD+ | Moderate; no outcome data |
| Nicotinamide mononucleotide (NMN) | 2022 randomized double-blind trial (Liao, 2022) | Raised blood NAD+ and improved aerobic capacity during training | Moderate; long-term safety data limited |
| Spermidine | Prospective population study of over 800 adults (Kiechl, 2018); SmartAge randomized trial (2022) | Higher dietary intake linked to lower mortality; supplement trial results on memory are mixed | Moderate to promising |
| Resveratrol | 30-day trial in adults with obesity (Timmers, 2011) | Some improvement in metabolic markers; low bioavailability | Mixed |
| Fisetin | Mayo Clinic AFFIRM trial, results still being published | Human senolytic effect not yet established | Early |
| Rapamycin (sirolimus, off label) | mTOR inhibitor trial in older adults (Mannick, 2014) | Improved vaccine immune response; no human lifespan data | Strong in animals; very limited in humans |
| Metformin (off label) | TAME trial, not yet reported | Observational links to longer survival in diabetes only | Unconfirmed in people without diabetes |
Read the table as a map of where evidence exists, not a ranking of what to take. CoQ10 and collagen rank highest on human trial quality for specific outcomes, NAD+ precursors and spermidine sit in the middle, and fisetin, rapamycin and metformin still wait on human aging trials.
NAD+ Precursors: NMN and NR
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every cell in the body. It plays a central role in energy metabolism, DNA repair, and the activity of sirtuins, a family of proteins linked to longevity. NAD+ levels decline significantly with age, dropping by as much as 50% between the ages of 40 and 60 [2].
Two main precursors are used to boost NAD+ levels:
Nicotinamide mononucleotide (NMN): Animal studies have shown impressive results, including improved insulin sensitivity, better endurance, and enhanced vascular function in aged mice [3]. A 2022 randomized controlled trial in healthy middle-aged adults found that 250 mg of NMN daily for 12 weeks increased blood NAD+ levels and improved aerobic capacity during exercise training [4]. However, long-term safety data in humans is still limited.
Nicotinamide riboside (NR): NR has been studied in slightly more human trials than NMN. A 2018 trial showed NR was well tolerated at 1,000 mg daily and successfully raised NAD+ levels in older adults [5]. Effects on clinically meaningful endpoints like disease prevention or lifespan extension have not been demonstrated in humans yet.
Evidence level: Moderate. Strong mechanistic rationale and promising early human data, but no long-term outcome studies confirming actual lifespan or healthspan extension in people.
Oral NAD+ precursors or NAD+ IV therapy?
Oral NMN and NR are dietary supplements taken by mouth. Some longevity and functional medicine clinics also offer NAD+ itself by intravenous infusion, which is a separate, cash-pay service with less published trial data for aging than the oral precursors. The NAD+ IV therapy guide explains what an infusion involves and where the evidence stops, and a side-by-side look at NAD+ IV versus oral supplements covers cost and convenience trade-offs. For the difference between the two precursors themselves, see NMN vs NR.
Resveratrol
Resveratrol is a polyphenol found in red grapes, berries, and peanuts. It gained fame through studies on caloric restriction mimetics and sirtuin activation. In animal models, resveratrol has improved cardiovascular markers, reduced inflammation, and in some cases extended lifespan in short-lived organisms like yeast and certain fish species [6].
In humans, the picture is more complicated. Bioavailability is low, meaning most orally consumed resveratrol is rapidly metabolized and excreted. Clinical trials have shown some benefits for glucose metabolism and inflammatory markers, particularly in people with metabolic syndrome or type 2 diabetes [7]. However, the doses used in successful animal studies are very difficult to replicate in humans through supplementation alone.
Evidence level: Mixed. Some benefits for specific metabolic markers in humans, but the sweeping anti-aging claims outpace the current evidence. Bioavailability remains a significant limitation.
Coenzyme Q10 (CoQ10)
CoQ10 is a naturally occurring antioxidant that supports mitochondrial energy production. Levels decline with age and are further reduced by statin medications. CoQ10 supplementation has the strongest evidence in cardiovascular health. The Q-SYMBIO trial, a randomized controlled trial of 420 patients with heart failure, found that 300 mg of CoQ10 daily significantly reduced major adverse cardiovascular events over two years [8].
For general anti-aging purposes, CoQ10 may help combat mitochondrial dysfunction and oxidative stress, two of the hallmarks of aging. Some research suggests benefits for skin aging when applied topically or taken orally, though these studies tend to be small [9].
Evidence level: Good for cardiovascular support and mitochondrial function. Moderate for broader anti-aging effects. One of the better-studied supplements on this list.
Collagen Peptides
Collagen is the most abundant protein in the body, forming the structural scaffolding for skin, joints, and connective tissue. Collagen production declines approximately 1% per year after age 20. Supplemental collagen peptides (hydrolyzed collagen, also sold as collagen hydrolysate) have become enormously popular.
The evidence is actually more positive than many skeptics expect. A 2019 meta-analysis of 11 randomized controlled trials found that oral collagen supplementation significantly improved skin hydration, elasticity, and wrinkle appearance compared to placebo, and a 2021 systematic review and meta-analysis by de Miranda and colleagues in the International Journal of Dermatology reached a similar conclusion [10]. Joint health studies have also shown benefits, particularly for osteoarthritis symptoms and exercise-related joint pain.
The main limitation is that these studies focus on specific tissues (skin, joints) rather than systemic aging processes. Collagen supplements are not addressing the core hallmarks of aging at a cellular level.
Evidence level: Good for skin and joint outcomes. Not a true systemic anti-aging intervention, but a well-supported supplement for age-related tissue changes.
Is oral collagen bioavailable? The evidence and the skeptics' case
Oral collagen is bioavailable in a specific, limited sense. The gut does not absorb collagen as an intact triple-helix protein: stomach acid and digestive enzymes break it down into free amino acids and short chains of two or three amino acids. Some of those short chains, especially prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly), resist further digestion and appear in human blood after a dose, according to Iwai and colleagues (2005, Journal of Agricultural and Food Chemistry).
How collagen peptides are thought to work
Collagen is built from a repeating pattern in which every third amino acid is glycine, with proline and hydroxyproline filling many of the other positions. The leading hypothesis is that circulating Pro-Hyp and similar peptides act as signals, prompting fibroblasts in the skin and chondrocytes in cartilage to make more of their own collagen and hyaluronic acid. That signaling effect is supported mainly by cell and animal studies, so the step from “the peptide is in the blood” to “the peptide rebuilds skin” is still an inference in humans.
Why skeptics doubt collagen supplements
Collagen skepticism rests on four limitations that the trial literature has not fully answered:
- No targeting. Ingested collagen is not routed to the skin or joints. Its amino acids join the body’s general pool, where they can be used for any protein.
- An incomplete protein. Collagen contains no tryptophan, so as a protein source it is lower quality than whey, eggs or soy. Some skeptics argue that any adequate protein intake supplies the same building blocks.
- Weak trial design. Many collagen trials are small, run for a few months or less, and use instrument readings such as skin hydration and elasticity rather than outcomes a person would notice. Placebo groups often receive no protein at all, which makes it hard to separate a collagen-specific effect from extra protein.
- Funding. A large share of collagen research is paid for by ingredient manufacturers. Industry funding does not invalidate a study, but independent reviewers note that the most favorable results tend to come from sponsored trials.
What the evidence supports today
The balanced reading is that oral collagen peptides produce modest, measurable improvements in skin hydration and elasticity and may ease some osteoarthritis and activity-related joint pain. The evidence does not support claims that collagen slows whole-body aging, and trial doses are measured in grams per day, far more than a capsule or a scoop of a blended “beauty” product often contains. Collagen peptides are a food supplement, which is different from the injectable signaling peptides covered in the peptide therapy guide or the copper peptide in GHK-Cu skin products.
Spermidine
Spermidine is a naturally occurring polyamine found in wheat germ, soybeans, aged cheese, and mushrooms. It induces autophagy, the cellular recycling process that clears damaged proteins and organelles. Autophagy declines with age, and this decline is implicated in many age-related diseases [11].
Animal studies have been consistently promising. Spermidine supplementation has extended lifespan in yeast, flies, worms, and mice. In mice specifically, it has shown cardioprotective effects and reduced age-related cognitive decline.
Human data is earlier-stage but encouraging. An epidemiological study following over 800 participants found that higher dietary spermidine intake was associated with reduced overall mortality [12]. A small randomized trial in older adults with subjective cognitive decline showed improved memory performance with spermidine supplementation. A larger and longer follow-up, the SmartAge randomized trial (Schwarz and colleagues, JAMA Network Open, 2022), did not find a significant memory benefit over placebo, so the cognitive results remain mixed.
Evidence level: Moderate to promising. Strong mechanistic rationale (autophagy induction), consistent animal data, and early supportive human evidence. One of the more interesting supplements in the longevity space.
Fisetin
Fisetin is a flavonoid found in strawberries, apples, and onions. It has gained attention primarily as a senolytic, meaning it may help clear senescent “zombie” cells that accumulate with age and drive chronic inflammation and tissue dysfunction [13]. It is frequently compared with the original senolytic drug pairing, dasatinib and quercetin.
In a widely cited 2018 study, fisetin extended lifespan in mice even when administered late in life. It reduced senescent cell burden in multiple tissues. The Mayo Clinic has been conducting human trials (the AFFIRM trial) to evaluate fisetin’s senolytic effects, though full results are still being published.
Evidence level: Early. Very promising animal data. Human trials are underway but not yet sufficient to make strong clinical recommendations. The senolytic mechanism is scientifically well-grounded.
Rapamycin (Off-Label)
Rapamycin is an FDA-approved immunosuppressant drug used in organ transplant patients. It inhibits mTOR (mechanistic target of rapamycin), a nutrient-sensing pathway that, when chronically activated, accelerates aging. Rapamycin has extended lifespan in every organism tested, including mice at various ages and genetic backgrounds [14].
Some longevity-focused physicians prescribe low-dose, intermittent rapamycin off-label. The rationale is that brief mTOR inhibition may mimic some benefits of caloric restriction without the need for constant dietary restriction. Early human data suggests low doses may actually enhance certain immune functions in older adults rather than suppress them, which was an unexpected finding [15].
However, rapamycin is a prescription medication with real side effects, including impaired wound healing, elevated blood lipids, and potential glucose dysregulation at higher doses. It should only be used under close medical supervision.
Evidence level: Strong animal data, the strongest of any compound on this list for lifespan extension. Very limited but intriguing human data for anti-aging purposes specifically. Not a supplement; it is a prescription drug with genuine risks.
Metformin (Off-Label)
Metformin is a first-line diabetes medication that has attracted enormous interest in the longevity community. Observational studies have suggested that diabetic patients taking metformin may actually live longer than non-diabetic controls, which is a striking finding given the health burden of diabetes [14].
Metformin activates AMPK, reduces mTOR signaling, decreases inflammation, and may influence multiple aging pathways. The TAME (Targeting Aging with Metformin) trial is a landmark clinical trial designed to test whether metformin can delay age-related diseases in non-diabetic older adults. As of now, the trial is underway but has not yet reported final results.
Common side effects include gastrointestinal discomfort (nausea, diarrhea), and there is some concern that metformin may blunt exercise-induced mitochondrial adaptations, which is relevant for people who use vigorous exercise as part of their longevity strategy [14].
Evidence level: Moderate to strong for metabolic health and disease risk reduction. The specific anti-aging effect in healthy, non-diabetic individuals is still unproven pending TAME trial results. Like rapamycin, this is a prescription drug, not a supplement.
How to Evaluate Anti-Aging Supplement Claims
When assessing any anti-aging supplement, consider these questions:
- Is there human data, or only animal/cell studies? Many compounds that extend lifespan in worms or mice fail to show similar effects in humans. The translational gap is real.
- What outcomes were measured? A supplement that raises a biomarker (like NAD+ levels) is not the same as one shown to reduce disease or extend lifespan. Surrogate endpoints matter, but clinical outcomes matter more.
- What were the study sizes and durations? Small, short-term studies can show effects that vanish in larger, longer trials.
- Who funded the research? Industry-funded studies are not automatically invalid, but they should be interpreted with awareness of potential bias.
- What is the dose and form used? The resveratrol in a glass of red wine is vastly different from the concentrated doses used in research.
Are anti-aging supplements checked by the FDA?
Dietary supplements do not need FDA approval before they are sold in the United States. Under the Dietary Supplement Health and Education Act of 1994, the manufacturer is responsible for a product’s safety and for keeping its label claims truthful, and the FDA mainly acts after a product reaches the market. In practice, the dose on the label, the purity of the ingredient and the evidence behind a claim all deserve a second look, and independent third-party testing seals add a layer of quality checking that the law does not require.
Practical Takeaways
If you are considering anti-aging supplements, here is a reasonable framework:
Well-supported for specific benefits (not necessarily lifespan): CoQ10, collagen peptides. These have good human evidence for targeted outcomes like cardiovascular support and skin/joint health.
Promising but still early: NMN, NR, spermidine, fisetin, and urolithin A. These have strong scientific rationale and encouraging early data, but the human evidence for actual aging outcomes is incomplete.
Requires medical supervision: Rapamycin, metformin. These are prescription medications with real risks and benefits. Do not self-prescribe based on longevity podcasts.
Overhyped relative to evidence: Resveratrol in supplement form, given the bioavailability challenges.
The most powerful anti-aging interventions, ones with consistent evidence across multiple studies, remain the basics: regular exercise (especially resistance training and cardiovascular fitness), adequate sleep, stress management, a nutrient-dense diet, and maintaining social connections. No pill replaces these.
Where clinic-based longevity treatments fit
Longevity clinics, functional medicine practices and integrative medicine physicians often go beyond oral supplements. Common offerings include NAD+ IV infusions, injectable peptide therapy, IV vitamin drips and hormone therapy, usually overseen by a physician (MD or DO), a nurse practitioner or, in states that license them, a naturopathic doctor. Most of these services are cash pay, and most are not FDA approved for anti-aging use, so the evidence gaps described above apply with more cost attached.
If you want to compare providers, the national directory of clinics offering NAD+ IV therapy and the list of peptide therapy clinics show who offers each service by state and city. Listing order on Regenerated.com is not paid ranking, Featured slots are labeled and capped, Verified means a clinic has passed credential checks rather than paid for placement, and the directory is free for patients. Inclusion in the directory is not an endorsement, and the guide to Featured, Verified and organic listings explains each label.
When to See a Doctor
Talk to a healthcare provider before starting any anti-aging supplement regimen, especially if you:
- Take prescription medications (many supplements interact with drugs, particularly blood thinners and immunosuppressants)
- Have a history of cancer (some supplements may influence cell growth pathways)
- Are considering off-label prescription drugs like rapamycin or metformin
- Have liver or kidney disease that could affect supplement metabolism
- Want to pursue a longevity-focused protocol involving multiple supplements simultaneously
A physician experienced in longevity medicine can help you prioritize interventions, order relevant biomarker testing, and monitor for safety. In Europe, BioProfile works this way, pairing a doctor-reviewed blood panel with a plan built from your own results; its online health scan is free to take from anywhere.
Frequently asked questions
Is oral collagen actually absorbed by the body?
Oral collagen is absorbed, but not as whole collagen. Digestion breaks hydrolyzed collagen into amino acids and small peptides, and some of those peptides, such as prolyl-hydroxyproline (Pro-Hyp), have been measured in human blood after a dose, according to Iwai and colleagues (2005). Whether those peptides then signal skin and cartilage cells to build new collagen is supported mainly by cell and animal studies, so the full mechanism in people is still unconfirmed.
Why are some experts skeptical of collagen supplements?
Experts are skeptical because collagen is digested like other proteins and is not delivered to the skin or joints, it lacks the amino acid tryptophan, and most collagen trials are small, short and funded by ingredient makers. Many trials also compare collagen with a placebo containing no protein. The randomized trials, including a 2019 meta-analysis of 11 of them, still show modest gains in skin hydration and elasticity, so the fair summary is a real but limited effect.
Which longevity supplements are supported by human trials?
CoQ10 and collagen peptides have the strongest human trial support, but for specific outcomes rather than aging itself. CoQ10 reduced major cardiovascular events in heart failure in the Q-SYMBIO trial, and collagen improved skin measures across randomized trials. NMN and NR raise blood NAD+ in human studies without outcome data, spermidine has observational support and mixed trial results, and fisetin, rapamycin and metformin still await human aging trial results.
Is NMN or NR better for raising NAD+?
Neither NMN nor NR has been shown to be better in a head-to-head outcome trial. Both raise blood NAD+ in randomized human studies: NR was well tolerated at 1,000 mg daily in a 2018 trial of middle-aged and older adults, and NMN raised NAD+ and aerobic capacity in a 2022 trial. NR has slightly more human trials behind it. Neither has evidence that it extends lifespan or prevents age-related disease in people.
Do anti-aging supplements need FDA approval?
Anti-aging supplements do not need FDA approval before they are sold. Under the Dietary Supplement Health and Education Act of 1994, manufacturers are responsible for safety and truthful labeling, and the FDA generally steps in only after problems appear. Rapamycin and metformin are different: they are FDA-approved prescription drugs for transplant medicine and diabetes, and using them for longevity is off label and requires a prescriber.
Is NAD+ IV therapy more effective than oral supplements?
NAD+ IV therapy has not been shown to be more effective than oral NMN or NR for aging. An infusion delivers NAD+ directly into the bloodstream, but published trials of IV NAD+ for longevity are scarce, while the oral precursors at least have randomized trials showing raised blood NAD+. IV infusions are cash pay at most clinics and a single session can take hours, so the trade-off is cost and time against an extra benefit no trial has shown.
The Bottom Line
The science of anti-aging supplementation is advancing rapidly, but honestly is still in its early chapters. Some compounds have genuine promise backed by solid mechanistic data and encouraging, if still limited, human trials. Others are trading on hype and extrapolation from animal studies.
For collagen, the answer to the skeptics is a qualified yes: oral collagen peptides are partly absorbed as small peptides and improve skin hydration and elasticity in randomized trials, but the trials are small, often sponsored, and say nothing about aging as a whole. CoQ10 holds the strongest outcome trial on this list, NAD+ precursors raise a biomarker without outcome data, and rapamycin and metformin remain prescription drugs awaiting human aging trials.
The most responsible approach is to stay curious, stay skeptical, prioritize lifestyle fundamentals, and work with a knowledgeable provider if you choose to add targeted supplements to your regimen.
Sources
- Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. doi:10.1016/j.cell.2022.11.001. PMID: 36599349. ↩
- Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. doi:10.1371/journal.pone.0042357. PMID: 22848760. ↩
- Mills KF, Yoshida S, Stein LR, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24(6):795-806. doi:10.1016/j.cmet.2016.09.013. PMID: 28068222. ↩
- Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2022;19(1):261-273. doi:10.1080/15502783.2022.2070996. PMID: 35872924. ↩
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7. PMID: 29599478. ↩
- Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342. doi:10.1038/nature05354. PMID: 17086191. ↩
- Timmers S, Konings E, de Vogel-van den Bosch J, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612-622. doi:10.1016/j.cmet.2011.10.002. PMID: 22055504. ↩
- Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649. doi:10.1016/j.jchf.2014.06.008. PMID: 25282031. ↩
- Žmitek K, Pogačnik T, Mervic L, Žmitek J, Pravst I. The effect of dietary intake of coenzyme Q10 on skin parameters and condition: results of a randomised, placebo-controlled, double-blind study. Biofactors. 2017;43(1):132-140. doi:10.1002/biof.1316. PMID: 27548886. ↩
- de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461. doi:10.1111/ijd.15518. PMID: 33742704. ↩
- Eisenberg T, Abdellatif M, Schroeder S, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22(12):1428-1438. doi:10.1038/nm.4222. PMID: 27841876. ↩
- Kiechl S, Pechlaner R, Willeit P, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr. 2018;108(2):371-380. doi:10.1093/ajcn/nqy102. PMID: 29955838. ↩
- Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. doi:10.1016/j.ebiom.2018.09.015. PMID: 30279143. ↩
- Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab. 2016;23(6):1060-1065. doi:10.1016/j.cmet.2016.05.011. PMID: 27304507. ↩
- Mannick JB, Del Giudice G, Sabber M, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268):268ra179. doi:10.1126/scitranslmed.3009892. PMID: 25540326. ↩